Omnipod 5 and the dexcom G6 - Closed Loop

 Financial Impact

A recent report from the American Diabetes Association reveals that the annual economic impact of diabetes in the United States has soared to a staggering $412.9 billion. While the prevalence of diabetes has remained relatively steady, the direct medical costs associated with the condition have surged by 7% between 2017 and 2022.

The Economic Costs of Diabetes in the U.S. in 2022, released by the ADA, provides a detailed examination of the financial toll of diabetes in the country. This comprehensive analysis, conducted every five years, underscores the significant burden placed on individuals and the healthcare system alike. Of the total cost, $306.6 billion accounts for direct medical expenses, while $106.3 billion represents indirect costs. Shockingly, individuals diagnosed with diabetes now consume a quarter of all healthcare spending in the U.S.

Chuck Henderson, CEO of the ADA, emphasizes the urgent need to address the escalating costs associated with diabetes. He notes that over the past decade, medical expenses for individuals with diabetes have surged by 35%, underscoring the immense financial strain faced by many, especially those from vulnerable and underserved communities. As November marks American Diabetes Month, Henderson urges policymakers and healthcare stakeholders to view the report as a rallying cry to prioritize affordable diabetes care.

Key findings from the report shed light on the primary cost drivers, including increased usage of prescription medications beyond glucose-lowering drugs, hospitalization rates, diminished work productivity, and elevated unemployment rates. Notable highlights include:

. Between 2017 and 2022, adjusted for inflation, direct medical costs for diabetes rose by 7%.

. National healthcare expenses attributed to diabetes have surged by $80 billion over the past

decade, reaching $307 billion in 2022.

. Individuals with diagnosed diabetes face medical expenditures 2.6 times higher than those without the condition.

• .The inflation-adjusted cost of insulin has surged by 24% from 2017 to 2022, with spending tripling over the past decade.
• 
  
• . Women with diabetes, despite lower prevalence rates, incur higher average annual healthcare costs compared to men.
• 
  
• . Black Americans with diabetes bear the highest direct healthcare expenses.
• 
  
• . Individuals aged 65 and above spend approximately twice as much per capita on annual healthcare costs compared to other age groups above 18.

Moreover, the report highlights the significant impact of diabetes on workforce productivity, with $106.3 billion attributed to lost productivity, absenteeism, and presenteeism. If individuals with diabetes were able to participate in the workforce at the same rate as their peers without the condition, it could potentially add 2 million more individuals aged 18 to 65 to the workforce.

The Economic Report was crafted by a diverse team of experts, including physicians, epidemiologists, economists, and researchers, reflecting a multidisciplinary effort to comprehensively assess the economic implications of diabetes in the U.S.

Edit This Article